Coagulation Market Research Reports & Industry Analysis
Coagulation factors have been implicated as independent factors in the development of myocardial infarction, stroke and deep vein thrombosis in some patients. With the increasing incidence of cardiovascular diseases, this discovery has brought what was a rather lackluster discipline into the limelight. The intensive investigation of coagulation processes has uncovered a number of other conditions in which coagulation factors are implicated, such as: post surgical bleeding due to the use of aspirin or Plavix, spontaneous abortion and pregnancy problems.
Demand for rapid decentralized coagulation testing is increasing. The number of patients needing coagulation testing is growing. More patients are using anticoagulants following implantation of mechanical heart valves or after atrial fibrillation. More recently patients are using antithrombotic agents after, or to prevent, deep venous thrombosis, arterial or pulmonary embolism, stroke, angina pectoris, and myocardial infarction. There is also increasing pressure to return results to clinicians rapidly so that anticoagulant therapy can be adjusted.
Coagulation Industry Research & Market Reports
-
In Vitro Diagnostics (IVD) in Malaysia, Singapore and Indonesia, 2022
... Southeast Asia has been identified as one of the key regions in APAC region offering significant opportunities for IVD companies. This report focuses on three IVD markets in Southeast Asia: Malaysia, Indonesia, and Singapore. These ... Read More
-
Coagulation Analyzers Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... has affected the economics and sectors of many different countries due to lockdowns, travel restrictions, and business closures. The outbreak of COVID-19 causes the global shutdown which compelled the manufacturers of coagulation analyzers to halt ... Read More
-
Global Heparin Market Report, History and Forecast 2017-2028
... size of US$ 5,381.53 million by 2028 with a CAGR of 12.64% during the forecast period 2022-2028. The global main manufacturers of Heparin include Hepalink, Changshan Pharm, Qianhong Bio-pharma, Opocrin, Pfizer, Aspen Oss, King-friend Biochemical ... Read More
-
United States Market for In Vitro Diagnostic (IVD) Tests
... state of flux, trying to manage a myriad of issues, all of which collide with a huge system that costs more than any other in the world. This latest report from Kalorama Information, United States ... Read More
-
Global Channel Coagulometer Market - 2022-2029
... % during the forecast period (2022-2029). A blood coagulometer is an analyzer used to test the coagulation efficiency of blood to diagnose and assess bleeding disorders such as hemophilia or monitor patients taking anticoagulant medicines ... Read More
-
Glycomic Therapeutics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Class (Isolated and Synthetic), Structures [Glycoproteins, Targeting Sialic Acid, Proteoglycans, Targeting Glycosaminoglycans, Glycosylphosphatidylinositol (GPI)-Anchored Proteins & Heparin Based Glycans, Targeting Glycosphingolipids, and Others], Indications (Thrombosis & Chemoprophylaxis, Anaemia, Anti-Adhesive & Anti-Inflammatory, Cataracts, Gaucher’s Disease, MPS-1 & IV, Cancer, Alzheimer’s Disease, Influenza Type A & B, and Others), and Mode of Action [Inhibits Neuraminidase; Inhibits Heparanase and Selectins and Blocks Interactions Between Growth Factors and Heparan Sulfate; Erythropoietin & Enzyme Replacement Therapy (ERT); Tissue Plasminogen Activator; Inhibits Glucosylceramide Synthase; Interleukin 1, 2 & 3; Beta & Gamma Interferons; and Others]
... Others], Indications (Thrombosis & Chemoprophylaxis, Anaemia, Anti-Adhesive & Anti-Inflammatory, Cataracts, Gaucher’s Disease, MPS-1 & IV, Cancer, Alzheimer’s Disease, Influenza Type A & B, and Others), and Mode of Action [Inhibits Neuraminidase; Inhibits Heparanase and Selectins ... Read More
-
Europe Prothrombin Complex Concentrate Market, By Type (3-Factor And 4-Factor); By End-User (Hospital, Ambulatory Services And Others), By Application (Acquired Coagulation Factor Deficiency, Congenital Coagulation Factor Deficiency And Others), By Country (Germany, United Kingdom, Italy, France, Spain, The Netherlands, Belgium, Russia, Poland, Portugal, Austria And Rest of Europe); Trend Analysis, Competitive Market Share & Forecast, 2018-2028
... France, Spain, The Netherlands, Belgium, Russia, Poland, Portugal, Austria And Rest of Europe); Trend Analysis, Competitive Market Share & Forecast, 2018-2028 Europe Prothrombin Complex Concentrate Market to Reach USD 409.5 Million by 2028 Europe's prothrombin ... Read More
-
In Vitro Diagnostics Market, by Product Type (Instruments and Reagents & Kits), by Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis, Urinalysis, and Others), by Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Disorders, and Others), by End User (Hospital, Pathology Laboratories, Point-of-Care Diagnostics, Research Institutes, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Autoimmune Disorders, and Others), by End User (Hospital, Pathology Laboratories, Point-of-Care Diagnostics, Research Institutes, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity ... Read More
-
Point-of-Care (POC) Coagulation Testing Devices Market (Product: Instruments/Analyzers and Consumables & Accessories) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
... on the global point-of-care coagulation testing devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from ... Read More
-
Diagnostic Reagents Market (Product Type: Chromatography Reagents, Molecular Diagnostic Reagents, Immunoassay Reagents, Clinical Chemistry Reagents, Flow Cytometry Reagents, Cell & Tissue Culture Reagents, Hematology & Hemostasis Reagents, Microbiology Reagents, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031
... Size, Share, Growth, Trends, and Forecast, 2021-2031 Diagnostic Reagents Market – Scope of Report TMR’s report on the global diagnostic reagents market studies the past as well as the current growth trends and opportunities to ... Read More
-
Global Heparin Market Size study, by Type (Low Molecular Weight Heparin, Ultra-low Molecular Weight Heparin, Unfractionated Heparin) by Route of Administration (Intravenous, Subcutaneous) by Application (Venous Thromboembolism, Atrial Fibrillation, Renal Impairment, Coronary Artery Disease, Others) by End-use (Outpatient, Inpatient) by Source (Porcine, Bovine, Others) and Regional Forecasts 2022-2028
... by End-use (Outpatient, Inpatient) by Source (Porcine, Bovine, Others) and Regional Forecasts 2022-2028 Global Heparin Market is valued approximately USD 7.3 billion in 2021 and is anticipated to grow with a healthy growth rate of ... Read More
-
Point of Care Testing Market Size By Product (Glucose Monitoring, Cardiometabolic Testing, Infectious Disease Testing, Coagulation Testing, Pregnancy & Fertility Testing, Tumor/Cancer Marker Testing, Urinalysis Testing, Cholesterol Testing, Hematology Testing, Drugs-of-Abuse Testing, Fecal Occult Testing), By Technology (Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics, Immunoassays, Agglutination Assays, Flow-Through, Solid Phase, Biosensors), By Prescription (OTC Testing, Prescription-based Testing), By Application (Cardio Metabolic Testing, Infectious Disease Testing, Nephrology Testing, Drug-of-Abuse (DoA) Testing, Blood Glucose Testing, Pregnancy Testing, Cancer Biomarker Testing), By End-use (Hospitals, Diagnostic Centers, Research Laboratories, Home-Care Settings), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2022 - 2030
... By Technology (Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics, Immunoassays, Agglutination Assays, Flow-Through, Solid Phase, Biosensors), By Prescription (OTC Testing, Prescription-based Testing), By Application (Cardio Metabolic Testing, Infectious Disease Testing, Nephrology Testing, Drug-of-Abuse (DoA) Testing, ... Read More
-
Hemostasis Products Market Size By Product (Topical Hemostasis Product {Gelatin, Polysaccharides , Oxidized Regenerated Cellulose, Collagen}), Infusible Hemostasis Products {Platelet Concentrate From Donor Blood, Fresh Frozen Plasma (FFP), Factor VIII, Prothrombin}), Advanced Hemostasis Products ({Flowable, Thrombin, Synthetic Sealants, Fibrin}), By Application (Trauma, Surgery, Hemophilia, Myocardial Infarction), By End-use (Hospitals, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 - 2030
... Thrombin, Synthetic Sealants, Fibrin}), By Application (Trauma, Surgery, Hemophilia, Myocardial Infarction), By End-use (Hospitals, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 - 2030 The hemostasis products ... Read More
-
2022 Global Forecast for Automated Coagulation Instrument Market (2023-2028 Outlook)-High Tech & Emerging Markets Report
... countries. The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales ... Read More
-
2022 Global Forecast for Automatic Hemostasis Analyzers Market (2023-2028 Outlook)-High Tech & Emerging Markets Report
... countries. The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales ... Read More
-
Global and China Recombinant Human Coagulation VIIa Market Status and Forecast 2022-2028
... market size is estimated to be worth US$ 1180 million in 2022 and is forecast to a readjusted size of US$ 1467 million by 2028 with a CAGR of 3.7% during the forecast period 2022-2028. ... Read More
-
Life Science Reagents Market (Product: Chromatography Reagents, Molecular Diagnostics Reagents, Immunoassay Reagents, Clinical Chemistry Reagents, Flow Cytometry Reagents, Cell & Tissue Culture Reagents, Hematology & Hemostasis Reagents, Microbiology Reagents, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
... Size, Share, Growth, Trends, and Forecast, 2022-2031 Life Science Reagents Market – Scope of Report TMR’s report on the global life science reagents market studies the past as well as the current growth trends and ... Read More
-
Hemophilia Treatment Market By Type (Hemophilia A, Hemophilia B), By Drug Therapy (Recombinant coagulation factor concentrates therapy, Plasma derived coagulation factor concentrates therapy, Non-factor replacement therapy, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
... global hemophilia treatment market was valued at $12,764.8 million in 2021, and is projected to reach $26,905.2 million by 2031, registering a CAGR of 7.5% from 2022 to 2031. Hemophilia is usually an inherited bleeding ... Read More
-
2022 Global Forecast for Antithrombin Market (2023-2028 Outlook)-High Tech & Emerging Markets Report
... global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product shipments ... Read More
-
Global Blood Plasma Fractionation Market Report, History and Forecast 2016-2027
... expected to reach US$ 44034 million by the end of 2027, with a CAGR of 7.63% between 2021 and 2027. Global Blood Plasma Fractionation Scope and Market Size The global Blood Plasma Fractionation market is ... Read More
-
Europe Heparin Market, By Product Type (Low Molecular Weight Heparin, Unfractionated Heparin, Ultra Low Molecular Weight Heparin), By End User (Hospitals, Blood and Stem Cell Bank, Others (Laboratories, Acute Care Centers)), and By Region (North America,
... America, Latin America, Europe, Asia Pacific, Middle East & Africa ) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Heparin is obtained naturally from mucosal tissues of slaughtered meat animals such as porcine ... Read More
-
Hemophilia Treatment Market, by Product Type (Plasma Derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Antifibrinolytic Agents, and Desmopressin), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Onl
... America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Hemophilia, a factor VIII deficiency, is a genetic disorder that is caused by the absence of the ... Read More
-
In-vitro Diagnostics Market - by Product Type (Instruments and Reagents & Kits), by Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis, Urinalysis, and Others), by Application (Infectious
... Autoimmune Disorders, and Others), by End User (Hospital, Pathology Laboratories, Point-of-Care Diagnostics, Research Institutes, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Trends, and ... Read More
-
2022 Global: Plasma Fractionation - Innovative Markets Forecast (2028) report
... 2028. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2017 to 2028 using regression analysis in ... Read More
-
China In-Vitro Diagnostics (IVD) Market, Impact of COVID-19, Size, Share, Regulations, Reimbursement, Major Deals, Key Players Analysis, Trends & Recent Developments - Forecast to 2028
... 21 Billion by 2028. China represents one of the largest clinical laboratory markets in the Asia-Pacific region, and the fastest growing among the top ten IVD country markets. Historically, large multinational companies have dominated IVD ... Read More
Research Assistance
